Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ollert

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Journal of Investigational Allergology & Clinical Immunology|July 26, 2024
Fecal IgE Analyses Reveal a Role for Stratifying Peanut-Allergic PatientsR Czolk, F Codreanu-Morel, L de Nies, et al.
Allergy|August 7, 2016
Application of recombinant antigen 5 allergens from seven allergy-relevant Hymenoptera species in diagnosticsM Schiener, B Eberlein, C Moreno-Aguilar, et al.
Allergy|June 23, 2015
Position paper of the EAACI: food allergy due to immunological cross-reactions with common inhalant allergensT Werfel, R Asero, B K Ballmer-Weber, et al.
Allergy|September 2, 2005
Association study of mast cell chymase polymorphisms with atopyS Weidinger, L Rümmler, N Klopp, et al.
Allergy|May 26, 2016
A new framework for the interpretation of IgE sensitization testsG Roberts, M Ollert, R Aalberse, et al.
Allergy|June 28, 2016
Cross-reactivity to fish and chicken meat - a new clinical syndromeA Kuehn, F Codreanu-Morel, C Lehners-Weber, et al.
Allergy|July 26, 2016
Infant milk formulas differ regarding their allergenic activity and induction of T-cell and cytokine responsesH Hochwallner, U Schulmeister, I Swoboda, et al.
Journal of Investigational Allergology & Clinical Immunology|July 27, 2023
From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe)B Sousa-Pinto, Y Palamarchuk, L Leemann, et al.
Cytogenetic and Genome Research|September 10, 2009
Targeted disruption of the mouse Npal3 gene leads to deficits in behavior, increased IgE levels, and impaired lung functionP Grzmil, J Konietzko, D Boehm, et al.
Allergy|April 25, 2026
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal PolypsL Klimek, J Mullol, S Reitsma, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Investigational Allergology & Clinical Immunology|July 26, 2024
Fecal IgE Analyses Reveal a Role for Stratifying Peanut-Allergic PatientsR Czolk, F Codreanu-Morel, L de Nies, et al.
Allergy|August 7, 2016
Application of recombinant antigen 5 allergens from seven allergy-relevant Hymenoptera species in diagnosticsM Schiener, B Eberlein, C Moreno-Aguilar, et al.
Allergy|June 23, 2015
Position paper of the EAACI: food allergy due to immunological cross-reactions with common inhalant allergensT Werfel, R Asero, B K Ballmer-Weber, et al.
Allergy|September 2, 2005
Association study of mast cell chymase polymorphisms with atopyS Weidinger, L Rümmler, N Klopp, et al.
Allergy|May 26, 2016
A new framework for the interpretation of IgE sensitization testsG Roberts, M Ollert, R Aalberse, et al.
Allergy|June 28, 2016
Cross-reactivity to fish and chicken meat - a new clinical syndromeA Kuehn, F Codreanu-Morel, C Lehners-Weber, et al.
Allergy|July 26, 2016
Infant milk formulas differ regarding their allergenic activity and induction of T-cell and cytokine responsesH Hochwallner, U Schulmeister, I Swoboda, et al.
Journal of Investigational Allergology & Clinical Immunology|July 27, 2023
From MASK-air and SILAM to CATALYSE (Climate Action To Advance HeaLthY Societies in Europe)B Sousa-Pinto, Y Palamarchuk, L Leemann, et al.
Cytogenetic and Genome Research|September 10, 2009
Targeted disruption of the mouse Npal3 gene leads to deficits in behavior, increased IgE levels, and impaired lung functionP Grzmil, J Konietzko, D Boehm, et al.
Allergy|April 25, 2026
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal PolypsL Klimek, J Mullol, S Reitsma, et al.
Pageof 6